Bioavailability / Bioequivalence - bebac.at
Study Designs (Single Dose / Multiple Dose) Single Dose recommended in most international Guidelines, but steady-state studies: may be required: in the case of dose- or time-dependent pharmacokinetics, for some modified release products (+ Single Dose BE). may be considered: if problems of sensitivity preclude sufficiently precise plasma
Download Bioavailability / Bioequivalence - bebac.at
Information
Domain:
Source:
Link to this page:
Documents from same domain
Practically meeting modified release BE …
bebac.at1 Practically meeting modified release BE (bioequivalence) require ments Innovations in Modified Release | Evening Seminar | Berlin , 8 November 201 1
Overview of Dissolution for BA/BE - bebac.at
bebac.atBiopharmaceutics Classification System based on Solubility/Permeability Dissolution rate has a negligible impact on bio- availability of highly soluble and highly perme-
rted Bine ai venit! - bebac.at
bebac.atWorkshop | Bucarest, 19 March 2013 1• 59 Sample Size Estimation for BE Studies Helmut Schütz BEBAC Helmut Schütz BEBAC Biostatistics Sample Size Estimation
Clinical part of BA/BE studies - BEBAC
bebac.atBioequivalence and Bioavailability, Pre -Conference Workshop | Ljubljana, 17 May 2010 1 • 73 3/6 | Clinical Part of BA/BE Studies informa life scienceslife sciences
Sample Size Calculations - bebac.at
bebac.at1 • 57 Sample Size Calculations In vitro in vivo Correlation (IVIVC), Biowaivers & Statistical Aspects of Bioequ ivalence in Drug Product Development | …
PK-NCA, PK based Design, Biostatistics (Part 1)
bebac.at3 • 144 PK – NCA, PK based Design, Biostatistics (Part I/II) Moscow, 23 May 2012 NCA vs. PK Modeling Pharmacokinetic models Useful for understanding the drug/formulation
Practically meeting modified release BE …
bebac.at3 Practically meeting modified release BE (bioequivalence) require ments Innovations in Modified Release | Evening Seminar | Berlin , 8 November 201 1
Introduction to Biostatistics - bebac.at
bebac.at2 • 57 Introduction to Biostatistics (1/3: Basic Concepts ) Biostatistics : Basic concepts & applicable principles for various designs in bioequivalence studies and data analysis | Mumbai , …
Sample Size Calculations - bebac.at
bebac.at1 • 49 Sample Size Calculations … or the Myth of Power Biostatistics : Basic concepts & applicable principles for various designs in bioequivalence studies and data analysis | Mumbai , …
Related documents
Gatekeeping procedures with clinical trial applications
users.iems.northwestern.eduGatekeeping procedures are defined as multiple testing procedures that meet the following condi-tions: * Type I error rate control: The familywise error rate (FWER ...
W-Multiplicity Problems in Clinical Trials – A Regulatory ...
www.bassconference.orgMultiplicity Problems in Clinical Trials – A Regulatory Perspective Mohammad F. Huque, Ph.D. Office of Biostatistics OTS, CDER/FDA Kathleen Fritsch, Ph.D., Division of Biometrics III, Office of Biostatistics, OTS, CDER, FDA
1 Medical Research is Based on Evidence
www.medicalbiostatistics.com1 HOME MedicalBiostatistics.com _____ The Basics of Medical Research For an updated version, see Basic Methods of Medical Research, Third Edition
Medical Statistics: Clinical Trials
www.nickfieller.staff.shef.ac.ukClinical Trials; Introduction © NRJF, 1996 1 Statistical Methods in Clinical Trials 0. Introduction 0.1 Books Altman, D.G. (1991) Practical Statistics for Medical ...
DOI:n ic a l & entalP Journal of Aman, Clin Exp Pharmacol ...
www.omicsonline.orgAberrant Behavior Checklist: Current Identity and Future Developments